PPT- Transfusion Therapy

According to a survey conducted by the Committee on Blood and Blood Products of the American Society of Anesthesiologistsmuch of all blood given to patients is during the perioperative period The anesthesiologist should be an expert on the implications and the complications associated with blood transfusions and should be a leader of acute transfusion medicine in the hospital setting. and Thrombosis. Maria . Domenica. . Cappellini. Erika . Poggiali. University . of Milan and . Policlinico. Foundation IRCCS. Milan, Italy. Clinical challenges in NTDT. Iron overload. Hypercoagulability. Dr Nishant Verma. Department of Pediatrics,. KGMU, Lucknow. Historical Time Line. 17. th. century- 1. st. recorded transfusion (from man to animal). 1901- Karl Landsteiner’s discovery of ABO grouping laid foundation for scientific transfusion practices. An Evidence-Based . Approach. Haneen . Yasin. Abdella, MD. Hematology Oncology . Kidz. Medical Services. Miami Children’s Hospital. Objectives. Review the definite indications for . leukoreduced. Department of Pediatrics,. KGMU, Lucknow. Historical Time Line. 17. th. century- 1. st. recorded transfusion (from man to animal). 1901- Karl Landsteiner’s discovery of ABO grouping laid foundation for scientific transfusion practices. Minh-Ha Tran. Learning Objectives. After participating in this activity, participants will be able to:. Utilize newfound knowledge of transfusion risk to provide informed consent for blood transfusion. Can you confidently abandon CMV seronegative products in the modern era of pre-storage leukoreduction?. Jeannie Callum, BA, MD, FRCPC. Really?. Are we still talking. about this in 2017?. Disclosure. Dr. Soheila . zareifar. Department of pediatric hematology/oncology. Shiraz university of medical sciences. Qeshm. 2018. Transfusion in Sickle Cell. In sickle cell disease transfusions improve blood flow by reducing the proportion of red cells capable of forming sickle hemoglobin polymer. . Mohammadreza. . Bordbar. , MD. Pediatric Hematologist. Associate professor of SUMS. Qeshm. island, 22 . feb. 2018. Introduction. Care for persons with SCD often lacks continuity. Two SCD-specific disease-modifying treatments (HU, blood transfusion) still underutilized. GI bleed. , . septic shock. , . cardiac surgery. , . TBI. , and in . most ICU patients. . . • Massive transfusion protocols (MTP) (e.g., trauma pts or massive GI bleed) target hemodynamic stability not a specific Hb. Among patients receiving MTP, . THALASSEMIA. It result from reduced or absent production of beta chain in globin.. Common Hereditary Hemoglobin disorder(HHD). A. ) . Beta- . Thalassemia:Major,Intermedia,Minor. (trait . or carrier). Infusion of . blood products . for the purpose of restoring circulating volume.. Administration . of blood and blood components requires knowledge of correct administration techniques and possible complications. Risk per . UNIT . Allergic. 3:100. Febrile . (. Leuko. -reduced Units). 1:100. TACO. 1:100. TRALI. 1:5,000. Sepsis. 1:5,000. Acute. hemolytic. 1:75,000. HBV. 1:160,000. HIV & HCV. 1:2. . million. .” . . –Robert Beal, past director of International Federation of Red Cross. Transfusions: History. 1660s: First experiments in blood transfusion, transfused dog blood to humans. Patient died and experiments were banned.. . . Red blood cells . Most . RBC products are derived by collection of 450-500 (±10.